Taylor Andrew Lawrence, CFO of Orchestra BioMed Holdings ($OBIO), made one open market purchase of $5,100 in shares over the last year, with the latest on August 25, 2025. This ranks 4,559th among nearly 5,000 insiders, far below the average $1.46 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 181000 | $0.00 | 632,493.0000 | 52,186,503 | 40.09% | 0.35% |
| Jan. 2, 2026 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 3452 | $4.31 | 451,493.0000 | 52,186,503 | 0.76% | 0.01% |
| Dec. 10, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 8670 | $4.67 | 454,945.0000 | 52,186,503 | 1.87% | 0.02% |
| Nov. 25, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 3071 | $5.35 | 463,615.0000 | 52,186,503 | 0.66% | 0.01% |
| Sept. 17, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 16102 | $2.46 | 466,686.0000 | 38,392,716 | 3.34% | 0.04% |
| Aug. 25, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | P | Common Stock, par value $0.0001 per share | 2000 | $2.55 | 482,788.0000 | 38,392,716 | 0.42% | 0.01% |
| Aug. 7, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | A | Common Stock, par value $0.0001 per share ("Common Stock") | 80000 | $0.00 | 480,788.0000 | 38,392,716 | 19.96% | 0.21% |
| June 11, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share ("Common Stock") | 28172 | $3.14 | 400,788.0000 | 38,235,409 | 6.57% | 0.07% |
| April 4, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | A | Common Stock, par value $0.0001 per share ("Common Stock") | 84000 | $0.00 | 428,960.0000 | 38,235,409 | 24.35% | 0.22% |
| Dec. 19, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | P | Common Stock, par value $0.0001 per share | 1000 | $4.83 | 344,960.0000 | 37,621,495 | 0.29% | 0.00% |
| Dec. 12, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 34403 | $5.03 | 343,960.0000 | 37,621,495 | 9.09% | 0.09% |
| May 8, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | A | Common Stock, par value $0.0001 per share ("Common Stock") | 100000 | $0.00 | 378,363.0000 | 35,777,877 | 35.92% | 0.28% |
| July 20, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Taylor Andrew Lawrence | Chief Financial Officer | A | Common Stock, par value $0.0001 per share ("Common Stock") | 278363 | $0.00 | 278,363.0000 | 34,613,466 | 9999.99% | 0.80% |